![Darrin Beaupre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darrin Beaupre
Directeur Technique/Scientifique/R&D chez
IDEAYA BIOSCIENCES, INC.
Fortune : - $ au 30/06/2026
Profil
Darrin M.
Beaupre is currently Chief Medical Officer at IDEAYA Biosciences, Inc. since 2022.
Formerly, Dr. Beaupre was Chief Medical Officer at Biosplice Therapeutics, Inc. from 2020 to 2022, Head-Early Development & Immunotherapy at Pharmacyclics LLC from 2012 to 2017, Medical Director at Amgen, Inc. from 2006 to 2012, Head-Early Oncology Development at Pfizer Inc., and Assistant Professor at Moffit Cancer Center.
Education includes a doctorate from The University of Texas Medical School At Houston and undergraduate and graduate degrees from the University of Lowell.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Darrin Beaupre
| Sociétés | Poste | Début |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 21/11/2022 |
Anciens postes connus de Darrin Beaupre
| Sociétés | Poste | Fin |
|---|---|---|
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical research company that develops small-molecule therapeutics for osteoarthritis & cancer | Directeur Technique/Scientifique/R&D | 01/11/2022 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01/02/2017 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/10/2012 |
Moffit Cancer Center | Corporate Officer/Principal | - |
| PFIZER INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Darrin Beaupre
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
University of Lowell
 University of Lowell Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Medical School At Houston
 The University of Texas Medical School At Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical research company that develops small-molecule therapeutics for osteoarthritis & cancer | Health Technology |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
Moffit Cancer Center |
Choisissez Zonebourse 
